Long QT Syndrome classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
==Classification== | ==Classification== | ||
The two most common types of LQTS are genetic and drug-induced. Genetic LQTS can arise from mutation to one of several genes. | The two most common types of LQTS are genetic and drug-induced. Genetic LQTS can arise from mutation to one of several genes. | ||
Following is a list of the most common mutations: | |||
{| class="wikitable" | |||
| '''Type''' || '''OMIM''' || '''Mutation''' || '''Notes''' | |||
|- | |||
| LQT1 || {{OMIM2|192500}} || alpha subunit of the slow delayed rectifier potassium channel ([[KvLQT1]] or KCNQ1) || The current through the heteromeric channel (KvLQT1 + minK) is known as I<sub>Ks</sub>. These mutations often cause LQT by reducing the amount of repolarizing current that is required to terminate the action potential, leading to an increase in the action potential duration (APD). These mutations tend to be the most common yet least severe. | |||
|- | |||
| LQT2 || {{OMIM2|152427}} || alpha subunit of the rapid delayed rectifier potassium channel ([[HERG]] + [[MiRP1]]) || Current through this channel is known as I<sub>Kr</sub>. This phenotype is also probably caused by a reduction in repolarizing current. | |||
|- | |||
| LQT3 || {{OMIM2|603830}} || alpha subunit of the [[sodium channel]] ([[SCN5A]]) ||Current through this channel is commonly referred to as I<sub>Na</sub>. Depolarizing current through the channel late in the action potential is thought to prolong APD. The late current is due to failure of the channel to remain inactivated and hence enter a bursting mode in which significant current can enter when it should not. These mutations are more lethal but less common. | |||
|- | |||
| LQT4 || {{OMIM2|600919}} || anchor protein [[Ankyrin B]] || LQT4 is very rare. Ankyrin B anchors the ion channels in the cell. | |||
|- | |||
| LQT5 || {{OMIM2|176261}} || beta subunit MinK (or [[KCNE1]]) which coassembles with[[KvLQT1]] || - | |||
|- | |||
| LQT6 || {{OMIM2|603796}} || beta subunit MiRP1 (or [[KCNE2]]) which coassembles with [[HERG]] || - | |||
|- | |||
| LQT7 || {{OMIM2|170390}} || potassium channel [[KCNJ2]] (or K<sub>ir</sub>2.1) ||The current through this channel and KCNJ12 (K<sub>ir</sub>2.2) is called I<sub>K1</sub>. LQT7 leads to [[Andersen-Tawil syndrome]]. | |||
|- | |||
| LQT8 || {{OMIM2|601005}} || alpha subunit of the [[calcium channel]] Cav1.2 encoded by the gene [[CACNA1c]]. || Leads to [[Timothy's syndrome]]. | |||
|- | |||
| LQT9 || || [[Caveolin 3]] || | |||
|- | |||
| LQT10 || || [[SCN4B]] || | |||
|} | |||
Drug induced LQT is usually a result of treatment by [[Antiarrhythmic agent|anti-arrhythmic]] drugs such as [[amiodarone]] or a number of other drugs that have been reported to cause this problem (e.g. [[cisapride]]). Some[[anti-psychotic]] drugs, such as [[Haloperidol]] and [[Ziprasidone]], have a prolonged QT interval as a rare side effect. Genetic mutations may make one more susceptible to drug induced LQT. | |||
==References== | ==References== | ||
Revision as of 04:57, 24 August 2012
|
Long QT Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Long QT Syndrome classification On the Web |
|
American Roentgen Ray Society Images of Long QT Syndrome classification |
|
Risk calculators and risk factors for Long QT Syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Classification
The two most common types of LQTS are genetic and drug-induced. Genetic LQTS can arise from mutation to one of several genes. Following is a list of the most common mutations:
| Type | OMIM | Mutation | Notes |
| LQT1 | 192500 | alpha subunit of the slow delayed rectifier potassium channel (KvLQT1 or KCNQ1) | The current through the heteromeric channel (KvLQT1 + minK) is known as IKs. These mutations often cause LQT by reducing the amount of repolarizing current that is required to terminate the action potential, leading to an increase in the action potential duration (APD). These mutations tend to be the most common yet least severe. |
| LQT2 | 152427 | alpha subunit of the rapid delayed rectifier potassium channel (HERG + MiRP1) | Current through this channel is known as IKr. This phenotype is also probably caused by a reduction in repolarizing current. |
| LQT3 | 603830 | alpha subunit of the sodium channel (SCN5A) | Current through this channel is commonly referred to as INa. Depolarizing current through the channel late in the action potential is thought to prolong APD. The late current is due to failure of the channel to remain inactivated and hence enter a bursting mode in which significant current can enter when it should not. These mutations are more lethal but less common. |
| LQT4 | 600919 | anchor protein Ankyrin B | LQT4 is very rare. Ankyrin B anchors the ion channels in the cell. |
| LQT5 | 176261 | beta subunit MinK (or KCNE1) which coassembles withKvLQT1 | - |
| LQT6 | 603796 | beta subunit MiRP1 (or KCNE2) which coassembles with HERG | - |
| LQT7 | 170390 | potassium channel KCNJ2 (or Kir2.1) | The current through this channel and KCNJ12 (Kir2.2) is called IK1. LQT7 leads to Andersen-Tawil syndrome. |
| LQT8 | 601005 | alpha subunit of the calcium channel Cav1.2 encoded by the gene CACNA1c. | Leads to Timothy's syndrome. |
| LQT9 | Caveolin 3 | ||
| LQT10 | SCN4B |
Drug induced LQT is usually a result of treatment by anti-arrhythmic drugs such as amiodarone or a number of other drugs that have been reported to cause this problem (e.g. cisapride). Someanti-psychotic drugs, such as Haloperidol and Ziprasidone, have a prolonged QT interval as a rare side effect. Genetic mutations may make one more susceptible to drug induced LQT.